Case | Age | Sex | Procedure | PVST | Onset | Symptom | Postoperative Af | DM | HT | History of organ infarction | Laterality of RI | Extent of RI | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  | Abdominal pain | Others |  |  |  |  |  |  |
1 | 80 | F | LUL | − | 5 days | − | − | − | − | − | − | R | Partial |
2 | 71 | F | LUL |  +  | 12 days | Abdominal pain | ND |  +  | − |  +  | − | B | Multiple |
3 | 53 | F | LUL | − | 3 days | Left flank pain | ND | − | − | − | − | L | Filling defect in the left RA |
4 | 52 | F | LUL | − | 6 h | Right upper abdominal pain | Fever | − | − | − | − | R | Partial, cortex |
10 | 61 | F | LUL |  +  | 4 days | Right abdominal pain | ND | ND | ND | ND | ND | R | Wedge shaped |
5 | 76 | M | LUL | − | 15 days | Left lower abdominal pain | Vomiting, diarrhea | ND | − | − | − | R | Extensive |
6 | 76 | M | LUL |  +  | 13 months | Right flank pain | ND | ND | ND | ND | ND | L | Large, wedge shaped |
7 | 70 | M | LUL | − | 4 days | Abdominal pain | Fever | − |  +  |  +  | − | R | ND (flip-flop enhancement) |
8 | 68 | M | LUL | − | 4 days | Left back pain | Nausea, vomiting | − | − |  +  | CI | L | ND (poor contrast) |
9 | 68 | M | LUL |  +  | 2 days | Left flank pain | ND | − | − | − | − | L | Large, excluding upper pole |
11 | 43 | M | LUL |  +  | 14 days | Left flank pain | Fever | − | − | − | − | L | Large, wedge shaped |
12 | 70 | M | LUL |  +  | 12 days | − | − | − | − |  +  | AMI | R | Partial, upper pole |
13 | 73 | M | LPn |  +  | 4 days | Left abdominal pain | − |  +  |  +  |  +  | − | L | Partial |
Case | Preoperative CRE (mg/dL) | Post-RI peak of CRE (mg/dL) | Elevation of LDH (peak; IU/L) | Other organ infarction | Anticoagulant therapy | References | ||
---|---|---|---|---|---|---|---|---|
 |  |  |  |  | Heparin | Warfarin | Other |  |
1 | ND | ND |  + (670) | − |  +  | - | − | [5] |
2 | 0.63 | ND | ND | Brain, spleen, SMA, |  +  |  +  | − | [8] |
3 | 0.71 | 0.83 |  + (370) | − |  +  |  +  | − | [9] |
4 | WNL | ND |  + (1764) | − | - | - | Dipyridamole | [10] |
10 | ND | ND | ND | − |  +  |  +  | − | [11] |
5 | ND | 1.44 | ND | SMA |  +  |  +  | − | [12] |
6 | ND | ND | ND | − |  +  |  +  | − | [13] |
7 | 0.9 | Mild elevation |  + (1402) | − | − | − | − | [14] |
8 | WNL | ND |  +  | RCIA |  +  |  +  | − | [15] |
9 | WNL | ND |  +  | IMA? |  +  |  +  | − | [16] |
11 | ND | 0.95 |  + (1530) | − |  +  |  +  | − | [17] |
12 | WNL | ND | ND | − |  +  | − | Rivaroxaban | [4] |
13 | 0.64 | 0.9 |  + (1129) | − |  +  |  +  | Edoxaban | Our case |